Research map: Editor’s Note: Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer

Back to the article

Papers in this map

  1. Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer · Nobuyuki Tanaka · 2010 · 27 citations · Cited by this paper
  2. Selected Articles from This Issue · 2026 · Related
  3. RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma model · 2026 · Related
  4. HDAC Inhibition Unlocks Tumor Plasticity and Enhances Immunotherapy Response in Myc-Driven Small Cell Lung Cancer · 2026 · Related
  5. Development of tandem canine CAR T cells to enable comparative studies of aggressive B-cell lymphoma · 2026 · Related
  6. Selected Articles from This Issue · 2026 · Related
  7. Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer · 2026 · Related
  8. Mutant-Selective T-cell Receptor Therapy for Solid Tumors · 2026 · Related
  9. Tinengotinib (TT-00420) inhibits tumor growth and overcomes multidrug resistance in gastrointestinal cancers · 2026 · Related
  10. PRMT5 Inhibition by SCR-6920 Downregulates HIF-1α and Exhibits Synergistic Antitumor Activity with Bevacizumab in Ovarian Cancer · 2026 · Related
  11. Fedratinib Induces Nonclassical G2–M Arrest via Mitotic Kinase Inhibition and Synergizes with Mitomycin C to Suppress Pancreatic Ductal Adenocarcinoma · 2026 · Related

Source: OpenAlex (CC0)